Related Experiment Video
Updated: Aug 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
[Secondary prevention of coronary heart disease]
1Medizinische Klinik und Poliklinik Innenstadt, München. vonschacky@medinn.med.uni-muenchen.de
Insights
Secondary prevention of coronary heart disease (CHD) focuses on high-risk individuals. Effective measures exist but implementation and doctor-patient collaboration remain challenging.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Secondary prevention of coronary heart disease (CHD) targets individuals post-myocardial infarction or with high cardiovascular risk (>20% in 10 years).
- Effective interventions are established, but their widespread implementation is suboptimal.
- Optimal long-term care requires close collaboration between family doctors and cardiologists, though this ideal is rarely achieved.
Purpose of the Study:
- To outline the target population for secondary prevention of CHD.
- To identify and evaluate the efficacy of established preventive measures.
- To discuss current challenges in implementing secondary prevention strategies and suggest optimal care models.
Main Methods:
- Literature review and synthesis of evidence-based guidelines for CHD secondary prevention.
- Analysis of risk factors and effective interventions.
- Discussion of implementation barriers and proposed care coordination models.
Main Results:
- Key effective measures include smoking cessation, blood pressure control, Mediterranean diet, omega-3 fatty acids, endurance sports, statin therapy, weight management (BMI 18.5-25), diabetes management, and specific medications (antiplatelets, beta-blockers, ACE inhibitors).
- Hormone replacement therapy and vitamin supplements are ineffective or potentially harmful.
- Current implementation of effective secondary prevention strategies is inadequate.
Conclusions:
- Risk-adapted secondary prevention is crucial for high-risk cardiovascular patients.
- A comprehensive approach integrating lifestyle modifications and evidence-based pharmacotherapy is essential.
- Improved healthcare system integration and patient-physician communication are vital for enhancing secondary prevention outcomes.
Abstract:
The target group for "secondary prevention"--better "risk-adapted prevention"--of CHD are individuals who have suffered a myocardial infarction or have indicator diseases or other risk factor constellations with a cardiovascular risk of > 20% in ten years. The indisputably effective measures include cessation of smoking, blood pressure control with appropriate medications, a Mediterranean diet, maritime omega-3 fatty acids, endurance sports, statin-based lipid management (LDL < 100 mg/dl, triglycerides < 200 mg/dl), a target BMI of 18.5-25, optimized diabetes management, use of platelet aggregation inhibitors, beta blockers and ACE inhibitors. Hormone replacement therapy or vitamin supplementation has been identified as ineffective or mildly dangerous. Other measures have either not become established, or only poorly so. Currently, implementation of the effective measures leaves much to be desired. Quality-controlled close cooperation by the family doctor and cardiologist arguably provides the best long-term care in the area of secondary prevention, but still remains utopian.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Preventive Healthcare Services